Cervical DysplasiaLife Extension Suggestions
A.D.A.M. Cervical Dysplasia. 2014. Available at: http://www.ncbi.nlm.nih.gov/pubmedhealth/PMH0002461/. Last accessed on October 29, 2014.
Abike F, Engin AB, Dunder I, Tapisiz OL, Aslan C, Kutluay L. Human papilloma virus persistence and neopterin, folate and homocysteine levels in cervical dysplasias. Archives of gynecology and obstetrics. Jul 2011;284(1):209-214.
Abraham AG, D'Souza G, Jing Y, Gange SJ, Sterling TR, Silverberg MJ, . . . Strickler HD. Invasive cervical cancer risk among HIV-infected women: a North American multicohort collaboration prospective study. Journal of acquired immune deficiency syndromes (1999). Apr 1 2013;62(4):405-413.
ACOG American College of Obstetricians and Gynecologists. Protect & Detect: What Women Should Know About Cancer. Available at: http://mail.ny.acog.org/website/ProtectDetect.pdf. 2011b. Last accessed 9/7/2014.
ACOG. American College of Obstetricians and Gynecologists. http://www.acog.org/Resources%20And%20Publications/. Resources & Publications page. Featured Committee Opinion: The Transition from Pediatric to Adult Health Care: Preventative Care for Young Women Aged 18 – 26 Years. 2013a. Last accessed 9/7/2014.
ACOG. American College of Obstetricians and Gynecologists. Cervical Cancer Screening. Available at: http://www.acog.org/Resources-And-Publications/Patient-Education-Pamphlets/Files/Cervical-Cancer-Screening. 2013c. Last accessed 9/7/2014.
ACOG. American College of Obstetricians and Gynecologists. Cervical Cancer Patient Education. Available at: http://www.acog.org/About-ACOG/ACOG-Districts/District-II/Cervical-Cancer-Patient-Education. 2011a. Last accessed 9/7/2014.
ACOG. American College of Obstetricians and Gynecologists. Cervical Cancer. Available at: http://www.acog.org/Patients/FAQs/Cervical-Cancer. 7/2014. Last accessed 9/28/2014.
ACOG. Patient education Fact Sheet. New Guidelines for Cervical Cancer Screening. American College of Obstetricians and Gynecologists. Available at: http://www.acog.org/~/media/For%20Patients/pfs004.pdf. 2013b. Last accessed 9/7/2014.
ACS. American Cancer Society. Learn About Cancer page. What are the key statistics about cervical cancer? Available at: http://www.cancer.org/cancer/cervicalcancer/detailedguide/cervical-cancer-key-statistics. Last updated 8/15/2014a. Accessed 3/9/2015.
ACS. American Cancer Society. Cervical Cancer. Available at: http://www.cancer.org/acs/groups/cid/documents/webcontent/003094-pdf.pdf. Last updated 8/15/2014b. Last accessed 9/7/2014.
ACS. American Cancer Society. Find Support & Treatment page. Lycopene. Available at: http://www.cancer.org/treatment/treatmentsandsideeffects/complementaryandalternativemedicine/dietandnutrition/lycopene. Last updated 5/13/2010. Accessed 2/2/2015.
ACS. American Cancer Society. Find Support & Treatment page. Vitamin D. Available at: http://www.cancer.org/treatment/treatmentsandsideeffects/complementaryandalternativemedicine/herbsvitaminsandminerals/vitamin-d. Last updated 1/17/2013. Last accessed 9/28/2014.
ACS. American Cancer Society. Find Support & Treatment page. Vitamin A, Retinoids, and Provitamin A Carotenoids. Available at: http://www.cancer.org/treatment/treatmentsandsideeffects/complementaryandalternativemedicine/herbsvitaminsandminerals/vitamin-a-and-beta-carotene. Last updated 5/4/2012. Accessed 2/2/2015.
ACS. American Cancer Society. Learn About Cancer page. What are the key statistics about cervical cancer? Available at: http://www.cancer.org/cancer/cervicalcancer/detailedguide/cervical-cancer-key-statistics. Last updated 8/15/2014a. Last accessed 9/7/2014.
Ahn WS, Yoo J, Huh SW, Kim CK, Lee JM, Namkoong SE, et al. Protective effects of green tea extracts (polyphenon E and EGCG) on human cervical lesions. Eur J Cancer Prev. 2003;12(5):383-90.
Arnheim Dahlstrom L, Andersson K, Luostarinen T, Thoresen S, Ogmundsdottir H, Tryggvadottir L, . . . Dillner J. Prospective seroepidemiologic study of human papillomavirus and other risk factors in cervical cancer. Cancer epidemiology, biomarkers & prevention: a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. Dec 2011;20(12):2541-2550.
Bagarazzi ML, Yan J, Morrow MP, Shen X, Parker RL, Lee JC, . . . Sardesai NY. Immunotherapy against HPV16/18 generates potent TH1 and cytotoxic cellular immune responses. Sci Transl Med. Oct 10 2012;4(155):155ra138.
Bartley J. Vitamin D: emerging roles in infection and immunity. Expert review of anti-infective therapy. Dec 2010;8(12):1359-1369.
Bell MC, Crowley-Nowick P, Bradlow HL, Sepkovic DW, Schmidt-Grimminger D, Howell P, Mayeaux EJ, Tucker A, Turbat-Herrera EA, Mathis JM. Placebo-controlled trial of indole-3-carbinol in the treatment of CIN. Gynecol Oncol. 2000;78(2):123-9.
Brogly SB, Perkins RB, Zepf D, Longtine J, Yang S. Human Papillomavirus Vaccination and Cervical Cytology in Young Minority Women. Sex Transm Dis. 2014 Aug;41(8):511-4.
Brookner CK, Agrawal A, Trujillo EV, Mitchell MF, Richards-Kortum RR. Safety analysis: relative risks of ultraviolet exposure from fluorescence spectroscopy and colposcopy are comparable. Photochemistry and photobiology. Jun 1997;65(6):1020-1025.
Butterworth CE, Jr. Effect of folate on cervical cancer. Synergism among risk factors. Annals of the New York Academy of Sciences. Sep 30 1992;669:293-299.
Butterworth CE, Jr., Hatch KD, Gore H, Mueller H, Krumdieck CL. Improvement in cervical dysplasia associated with folic acid therapy in users of oral contraceptives. The American journal of clinical nutrition. Jan 1982;35(1):73-82.
Butterworth CE, Jr., Hatch KD, Macaluso M, Cole P, Sauberlich HE, Soong SJ, . . . Baker VV. Folate deficiency and cervical dysplasia. JAMA: the journal of the American Medical Association. Jan 22-29 1992;267(4):528-533.
Casey PM, Long ME, Marnach ML. Abnormal cervical appearance: what to do, when to worry? Mayo Clinic proceedings. Mayo Clinic. Feb 2011;86(2):147-150; quiz 151.
Castle PE, Schiffman M, Wheeler CM, Solomon D. Evidence for frequent regression of cervical intraepithelial neoplasia-grade 2. Obstetrics and gynecology. Jan 2009;113(1):18-25.
CDC. Centers for Disease Control and Prevention. HPV Vaccine Cervarix: What You Need to Know. Available at: http://www.cdc.gov/vaccines/hcp/vis/vis-statements/hpv-cervarix.pdf. 5/3/2011. Accessed 2/24/2015.
CDC. Centers for Disease Control and Prevention. Human Papillomavirus (HPV): Genital HPV Infection – Fact Sheeet. Available at: http://www.cdc.gov/std/hpv.stdfact-hpv.htm. Last updated 3/20/2014. Accessed 2/19/2015.
Cervarix. Available at: http://www.cervarix.ca. Copyright 2012. Last accessed 9/7/2014.
Chen DZ, Qi M, Auborn KJ, Carter TH. Indole-3-carbinol and diindolylmethane induce apoptosis of human cervical cancer cells and in murine HPV16-transgenic preneoplastic cervical epithelium. J Nutr. 2001;131(12):3294-302.
Cholujova D, Jakubikova J, Czako B, Martisova M, Hunakova L, Duraj J, . . . Sedlak J. MGN-3 arabinoxylan rice bran modulates innate immunity in multiple myeloma patients. Cancer immunology, immunotherapy : CII. Mar 2013;62(3):437-445.
Davis AT, Chakraborty H, Flowers L, Mosunjac MB. Cervical dysplasia in women infected with the human immunodeficiency virus (HIV): a correlation with HIV viral load and CD4+ count. Gynecologic oncology. Mar 2001;80(3):350-354.
DDD. Drug Discovery & Development. Inovio’s HPV Immunotherapy Hits Primary Endpoint. Available at: http://www.dddmag.com/news/2014/07/inovios-hpv-immunotherapy-hits-primary-endpoint. 7/23/2014. Accessed 10/6/2014.
de Sanjose S, Quint WG, Alemany L, Geraets DT, Klaustermeier JE, Lloveras B, et al. Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study. Retrospective International Survey and HPV Time Trends Study Group. Lancet Oncol. 2010;11:1048–56.
De Strooper LM, Hesselink BA, Berkhof J, Meijer CJ, Snijders PJ, Steenbergen RD, Heideman DA. Combined CADM1/MAL methylation and cytology testing for colposcopy triage of high-risk HPV-positive women. Cancer Epidemiol Biomarkers Prev. 2014 [Epub ahead of print]
Delere Y, Bohmer MM, Walter D, Wichmann O. HPV vaccination coverage among women aged 18-20 years in Germany three years after recommendation of HPV vaccination for adolescent girls: results from a cross-sectional survey. Human vaccines & immunotherapeutics. Aug 2013;9(8):1706-1711.
Dugué PA, Rebolj M, Garred P, Lynge E. Immunosuppression and risk of cervical cancer. Expert Rev Anticancer Ther. 2013;13(1):29-42.
Dunne EF, Unger ER, Sternberg M, McQuillan G, Swan DC, Patel SS, et al. Prevalence of HPV infection among females in the United States. JAMA. 2007;297:813–9.
Echelman D, Feldman S. Management of cervical precancers: a global perspective. Hematology/oncology clinics of North America. Feb 2012;26(1):31-44.
Etter DJ, Zimet GD, Rickert VI. Human papillomavirus vaccine in adolescent women: a 2012 update. Current opinion in obstetrics & gynecology. Oct 2012;24(5):305-310.
FDA. U.S. Food and Drug Administration. FDA approves Gardasil 9 for prevention of certain cancers caused by five additional types of HPV. Available at: http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm426485.htm. Last updated 12/11/2014. Accessed 2/19/2015.
Ferris D, Samakoses R, Block SL, Lazcano-Ponce E, Restrepo JA, Reisinger KS, et al. Long-term Study of a Quadrivalent Human Papillomavirus Vaccine. Pediatrics. 2014 [Epub ahead of print]
Fiks AG. Improving HPV vaccination rates. LDI Issue Brief. 2014;19(1):1-4.
Flatley JE, McNeir K, Balasubramani L, Tidy J, Stuart EL, Young TA, Powers HJ. Folate status and aberrant DNA methylation are associated with HPV infection and cervical pathogenesis. Cancer epidemiology, biomarkers & prevention: a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. Oct 2009;18(10):2782-2789.
Fuchs K, Weitzen S, Wu L, Phipps MG, Boardman LA. Management of cervical intraepithelial neoplasia 2 in adolescent and young women. 2007. J Pediatr Adolesc Gynecol. 2007;20:269–74.
Fujii T, Takatsuka N, Nagata C, Matsumoto K, Oki A, Furuta R, . . . Yoshikawa H. Association between carotenoids and outcome of cervical intraepithelial neoplasia: a prospective cohort study. Int J Clin Oncol. Dec 2013;18(6):1091-1101.
Gajjar K, Ahmadzai AA, Valasoulis G, Trevisan J, Founta C, et al. Histology Verification Demonstrates That Biospectroscopy Analysis of Cervical Cytology Identifies Underlying Disease More Accurately than Conventional Screening: Removing the Confounder of Discordance. PLoS ONE. 2013; 9(1): e82416.
Ganguly C, Dutta K, Sanyal U, Roy C, Basu PS, Das S. Response of Cervical Intra-epithelial Lesions to Vitamin E Supplementation - A Preliminary Report. Asian Pac J Cancer Prev. 2001;2(4):305-308.
Garcia-Iglesias T, Del Toro-Arreola A, Albarran-Somoza B, Del Toro-Arreola S, Sanchez-Hernandez PE, Ramirez-Duenas MG, . . . Daneri-Navarro A. Low NKp30, NKp46 and NKG2D expression and reduced cytotoxic activity on NK cells in cervical cancer and precursor lesions. BMC cancer. 2009;9:186.
Gardasil. About Gardasil page: FAQs About Gardasil. Available at: http://www.gardasil.com/about-gardasil/faqs-about-gardasil/. Copyright © 2014c. Accessed 10/6/2014.
Gardasil. HPV & Your Child. Available at: http://www.gardasil.com/. Copyright © 2014a. Accessed 2/24/2015.
Gardasil. Patient Information about Gardasil®9. Available at: http://www.gardasil9.com/. 12/2014b. Accessed 2/24/2015.
Ghosh C, Baker JA, Moysich KB, Rivera R, Brasure JR, McCann SE. Dietary intakes of selected nutrients and food groups and risk of cervical cancer. Nutrition and cancer. 2008;60(3):331-341.
Goldie SJ, O'Shea M, Diaz M, Kim SY. Benefits, cost requirements and cost-effectiveness of the HPV16,18 vaccine for cervical cancer prevention in developing countries: policy implications. Reproductive health matters. Nov 2008;16(32):86-96.
Gonzalez CA, Travier N, Lujan-Barroso L, Castellsague X, Bosch FX, Roura E, . . . Riboli E. Dietary factors and in situ and invasive cervical cancer risk in the European prospective investigation into cancer and nutrition study. International journal of cancer. Journal international du cancer. Jul 15 2011;129(2):449-459.
Gulzar N, Copeland KF. CD8+ T-cells: function and response to HIV infection. Current HIV research. Jan 2004;2(1):23-37.
Higdon JV, Delage B, Williams DE, Dashwood RH. Cruciferous vegetables and human cancer risk: epidemiologic evidence and mechanistic basis. Pharmacol Res. 2007;55(3):224-36.
Ho GY, Einstein MH, Romney SL, Kadish AS, Abadi M, Mikhail M, et al. 2011. Risk factors for persistent cervical intraepithelial neoplasia grades 1 and 2: managed by watchful waiting. J Low Genit Tract Dist. 2011;15(4):268-75.
Hogewoning CJ, Bleeker MC, van den Brule AJ, Voorhorst FJ, Snijders PJ, Berkhof J, . . . Meijer CJ. Condom use promotes regression of cervical intraepithelial neoplasia and clearance of human papillomavirus: a randomized clinical trial. International journal of cancer. Journal international du cancer. Dec 10 2003;107(5):811-816.
Hosono S, Matsuo K, Kajiyama H, Hirose K, Suzuki T, Kawase T, et al. Association between dietary calcium and vitamin D intake and cervical carcinogenesis among Japanese women. Eur J Clin Nutr. 2010;64(4):400-9.
Hwang JH, Kim MK, Lee JK. Dietary supplements reduce the risk of cervical intraepithelial neoplasia. Int J Gynecol Cancer. 2010;20(3):398-403.
IARC. International Agency for Research on Cancer. Chapter 2: An introduction to cervical intraepithelial neoplasia (CIN). Available at: http://screening.iarc.fr/colpochap.php?chap=2. 2014. Last accessed 9/7/2014.
Jensen KE, Thomsen LT, Schmiedel S, Frederiksen K, Norrild B, van den Brule A, Iftner T, Kjær SK. Chlamydia trachomatis and risk of cervical intraepithelial neoplasia grade 3 or worse in women with persistent human papillomavirus infection: a cohort study. Sex Transm Infect. 2014 [Epub ahead of print]
Jia Y, Hu T, Hang CY, Yang R, Li X, Chen ZL, et al. Case-control study of diet in patients with cervical cancer or precancerosis in Wufeng, a high incidence region in China. Asian Pac J Cancer Prev. 2012;13(10):5299-302.
Joura EA, Giuliano AR, Iversen O-E, Bouchard C, Mao C, Mehlsen J, . . . Luxembourg A. A 9-Valent HPV Vaccine against Infection and Intraepithelial Neoplasia in Women. New England Journal of Medicine. 2015;372(8):711-723.
Kelly JG, Trevisan J, Scott AD, Carmichael PL, Pollock HM, Martin-Hirsch PL, Martin FL. Biospectroscopy to metabolically profile biomolecular structure: a multistage approach linking computational analysis with biomarkers. Journal of proteome research. Apr 1 2011;10(4):1437-1448.
Kim J, Kim MK, Lee JK, Kim JH, Son SK, Song ES, Lee KB, Lee JP, Lee JM, Yun YM. Intakes of vitamin A, C, and E, and beta-carotene are associated with risk of cervical cancer: a case-control study in Korea. Nutr Cancer. 2010;62(2):181-9.
Kim SY, Kim JW, Ko YS, Koo JE, Chung HY, Lee-Kim YC. Changes in lipid peroxidation and antioxidant trace elements in serum of women with cervical intraepithelial neoplasia and invasive cancer. Nutr Cancer. 2003;47(2):126-30.
Kjellberg L, Wadell G, Bergman F, Isaksson M, Angstrom T, Dillner J. Regular disappearance of the human papillomavirus genome after conization of cervical dysplasia by carbon dioxide laser. American journal of obstetrics and gynecology. Nov 2000;183(5):1238-1242.
Kohaar I, Kumar J, Thakur N, Hussain S, Niyaz MK, Das BC, et al. Homocysteine levels are associated with cervical cancer independent of methylene tetrahydrofolate reductase gene (MTHFR) polymorphisms in Indian population. Biomarkers. 2010;15(1):61-8.
Kumar S, Jena L, Daf S, Mohod K, Goyal P, Varma AK. hpvPDB: An Online Proteome Reserve for Human Papillomavirus. Genomics & informatics. Dec 2013;11(4):289-291.
Kwanbunjan K, Saengkar P, Cheeramakara C, Tangjitgamol S, Chitcharoenrung K. Vitamin B12 status of Thai women with neoplasia of the cervix uteri. Southeast Asian J Trop Med Public Health;37 Suppl 3. 2006:178-83.
Kwasniewska A, Tukendorf A, Gozdzicka-Jozefiak A, Semczuk-Sikora A, Korobowicz E. Content of folic acid and free homocysteine in blood serum of human papillomavirus-infected women with cervical dysplasia. European journal of gynaecological oncology. 2002;23(4):311-316.
Langers I, Renoux V, Reschner A, Touze A, Coursaget P, Boniver J, . . . Jacobs N. Natural killer and dendritic cells collaborate in the immune response induced by the vaccine against uterine cervical cancer. European journal of immunology. Dec 2014;44(12):3585-3595.
La Vecchia C, Boccia S. Oral contraceptives, human papillomavirus and cervical cancer. European journal of cancer prevention: the official journal of the European Cancer Prevention Organisation (ECP). Mar 2014;23(2):110-112.
Lee GJ, Chung HW, Lee KH, Ahn HS. Antioxidant vitamins and lipid peroxidation in patients with cervical intraepithelial neoplasia. J Korean Med Sci. 2005;20(2):267-72.
Lee JK, So KA, Piyathilake CJ, Kim MK. Mild obesity, physical activity, calorie intake, and the risks of cervical intraepithelial neoplasia and cervical cancer. PLoS One. 2013;12;8(6):e66555.
Liddon NC, Leichliter JS, Markowitz LE. Human Papillomavirus Vaccine and Sexual Behavior Among Adolescent and Young Women. Am J Prev Med. 2012;42:44–52.
Liu JJ, Ward RL. Folate and one-carbon metabolism and its impact on aberrant DNA methylation in cancer. Advances in genetics. 2010;71:79-121.
Liu T, Soong SJ, Wilson NP, Craig CB, Cole P, Macaluso M, Butterworth CE, Jr. A case control study of nutritional factors and cervical dysplasia. Cancer epidemiology, biomarkers & prevention: a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. Nov-Dec 1993;2(6):525-530.
Luna J, Plata M, Gonzalez M, Correa A, Maldonado I, Nossa C, . . . Saah A. Long-term follow-up observation of the safety, immunogenicity, and effectiveness of Gardasil in adult women. PloS one. 2013;8(12):e83431.
Marais D, Gawarecki D, Allan B, Ahmed K, Altini L, Cassim N, Gopolang F,et al. The effectiveness of Carraguard, a vaginal microbicide, in protecting women against high-risk human papillomavirus infection. Antivir Ther. 2011;16(8):1219-26.
Mayeaux EJ, Jr., Harper MB. Loop electrosurgical excisional procedure. The Journal of family practice. Feb 1993;36(2):214-219.
McClung EC, Blumenthal PD. Efficacy, safety, acceptability and affordability of cryotherapy: a review of current literature. Minerva ginecologica. Apr 2012;64(2):149-171.
McCormack PL. Quadrivalent Human Papillomavirus (Types 6, 11, 16, 18) Recombinant Vaccine (Gardasil®): A Review of Its Use in the Prevention of Premalignant Anogenital Lesions, Cervical and Anal Cancers, and Genital Warts. Drugs. Jul 2014;74(11):1253-1283.
Mir S, Domjahn B, Ault KA. Investigating human papillomavirus 16 methylation as a biomarker for high-grade cervical intraepithelial neoplasia. Obstet Gynecol. 2014;123 Suppl 1:184S-5S.
Moore K, Cofer A, Elliot L, Lanneau G, Walker J, Gold MA. Adolescent cervical dysplasia: histologic evaluation, treatment, and outcomes. American journal of obstetrics and gynecology. Aug 2007;197(2):141.e141-146.
Myung SK, Ju W, Kim SC, Kim H. Vitamin or antioxidant intake (or serum level) and risk of cervical neoplasm: a meta-analysis. BJOG. 2011;118(11):1285-91.
NCI. National Cancer Institute. Bethesda 2001: A Revised System for Reporting Pap Test Results Aims to Improve Cervical Cancer Screening. Available at: http://www.cancer.gov/newscenter/newsfromnci/2002/bethesda2001. 4/23/2002. Last accessed 9/28/2014.
NCI. National Cancer Institute. Diethylstilbestrol (DES) and Cancer. Available at: http://www.cancer.gov/cancertopics/factsheet/Risk/DES. Last updated 10/5/2011a. Last accessed 9/7/2014.
NCI. National Cancer Institute. HPV and Cancer. Available at: http://www.cancer.gov/cancertopics/factsheet/Risk/HPV. 3/15/2012. Last accessed 9/7/2014.
NCI. National Cancer Institute. Human Papillomavirus (HPV) Vaccines. Available at: http://www.cancer.gov/cancertopics/factsheet/prevention/HPV-vaccine. 12/29/2011b. Last accessed 9/28/2014.
OSU. Ohio State University webpage. About Cervical Cancer. Available at: http://cancer.osu.edu/cancer-specialties/cancer-care-and-treatment/gynecologic-cancers/cervical-cancer. Copyright 2015. Accessed 2/2/2015.
Palan PR, Mikhail MS, Goldberg GL, Basu J, Runowicz CD, Romney SL. Plasma levels of beta-carotene, lycopene, canthaxanthin, retinol, and alpha- and tau-tocopherol in cervical intraepithelial neoplasia and cancer. Clin Cancer Res. 1996;2(1):181-5.
Palan PR, Mikhail MS, Shaban DW, Romney SL. 2003. Plasma concentrations of coenzyme Q10 and tocopherols in cervical intraepithelial neoplasia and cervical cancer. Eur J Cancer Prev. 2003;12(4):321-6.
Palan PR, Woodall AL, Anderson PS, Mikhail MS. Alpha-tocopherol and alpha-tocopheryl quinone levels in cervical intraepithelial neoplasia and cervical cancer. Am J Obstet Gynecol. 2004;190(5):1407-10.
Pathak S, Bajpai D, Banerjee A, Bhatla N, Jain SK, Jayaram HN, Singh N. Serum one-carbon metabolites and risk of cervical cancer. Nutrition and cancer. 2014;66(5):818-824.
Pathak S, Bhatla N, Singh N. Cervical cancer pathogenesis is associated with one-carbon metabolism. Molecular and cellular biochemistry. Oct 2012;369(1-2):1-7.
Peng YM, Peng YS, Childers JM, Hatch KD, Roe DJ, Lin Y, Lin P. Concentrations of carotenoids, tocopherols, and retinol in paired plasma and cervical tissue of patients with cervical cancer, precancer, and noncancerous diseases. Cancer epidemiology, biomarkers & prevention: a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. Apr 1998;7(4):347-350.
Perkins RB, Pierre-Joseph N, Marquez C, Iloka S, Clark JA. Parents' opinions of mandatory human papillomavirus vaccination: does ethnicity matter? Women's health issues: official publication of the Jacobs Institute of Women's Health. Nov-Dec 2010;20(6):420-426.
Piyathilake CJ, Henao OL, Macaluso M, Cornwell PE, Meleth S, Heimburger DC, Partridge EE. Folate is associated with the natural history of high-risk human papillomaviruses. Cancer research. Dec 1 2004;64(23):8788-8793.
Purandare NC, Trevisan J, Patel II, Gajjar K, Mitchell AL, Theophilou G, Valasoulis G, et al. Exploiting biospectroscopy as a novel screening tool for cervical cancer: towards a framework to validate its accuracy in a routine clinical setting. Bioanalysis. 2013;5(21):2697-711.
Radtke AL, Quayle AJ, Herbst-Kralovetz MM. Microbial products alter the expression of membrane-associated mucin and antimicrobial peptides in a three-dimensional human endocervical epithelial cell model. Biology of reproduction. Jun 2012;87(6):132.
Rodríguez A, Kleinbeck K, Mizenina O, Kizima L, Levendosky K, Jean-Pierre N, et al. In vitro and in vivo evaluation of two carrageenan-based formulations to prevent HPV acquisition. Antiviral Res. 2014 Aug;108:88-93.
Romney SL, Duttagupta C, Basu J, Palan PR, Karp S, Slagle NS, et al. Plasma vitamin C and uterine cervical dysplasia. Am J Obstet Gynecol. 1985;151(7):976-80.
Roura E, Castellsague X, Pawlita M, Travier N, Waterboer T, Margall N, . . . Riboli E. Smoking as a major risk factor for cervical cancer and pre-cancer: results from the EPIC cohort. International journal of cancer. Journal international du cancer. Jul 15 2014;135(2):453-466.
Sasagawa T, Takagi H, Makinoda S. Immune responses against human papillomavirus (HPV) infection and evasion of host defense in cervical cancer. Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy. Dec 2012;18(6):807-815.
Sauvaget C, Muwonge R, Sankaranarayanan R. Meta-analysis of the effectiveness of cryotherapy in the treatment of cervical intraepithelial neoplasia. International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics. Mar 2013;120(3):218-223.
Schafer A, Friedmann W, Mielke M, Schwartlander B, Koch MA. The increased frequency of cervical dysplasia-neoplasia in women infected with the human immunodeficiency virus is related to the degree of immunosuppression. American journal of obstetrics and gynecology. Feb 1991;164(2):593-599.
Schiff MA, Patterson RE, Baumgartner RN, Masuk M, van Asselt-King L, Wheeler CM, Becker TM. Serum carotenoids and risk of cervical intraepithelial neoplasia in Southwestern American Indian women. Cancer epidemiology, biomarkers & prevention: a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. Nov 2001;10(11):1219-1222.
Schiffman M, Castle PE, Jeronimo J, Rodriguez AC, Wacholder S. Human papillomavirus and cervical cancer. Lancet. Sep 8 2007;370(9590):890-907.
Schulte-Uebbing C, Schlett S, Craiut I, Antal L, Olah H. Chronical cervical infections and dysplasia (CIN I, CIN II): Vaginal vitamin D (high dose) treatment: A new effective method? Dermatoendocrinol. 2014;6(1):e27791.
Sepkovic DW, Raucci L, Stein J, Carlisle AD, Auborn K, Ksieski HB, . . . Bradlow HL. 3,3'-Diindolylmethane increases serum interferon-gamma levels in the K14-HPV16 transgenic mouse model for cervical cancer. In vivo (Athens, Greece). Mar-Apr 2012;26(2):207-211.
Sepkovic DW, Stein J, Carlisle AD, Ksieski HB, Auborn K, Bradlow HL. Diindolylmethane inhibits cervical dysplasia, alters estrogen metabolism, and enhances immune response in the K14-HPV16 transgenic mouse model. Cancer Epidemiol Biomarkers Prev. 2009;18(11):2957-64.
Silva C, Almeida EC, Côbo Ede C, Zeferino VF, Murta EF, Etchebehere RM. A retrospective study on cervical intraepithelial lesions of low-grade and undetermined significance: evolution, associated factors and cytohistological correlation. Sao Paulo Med. 2014;132(2):92-6.
Simon S. FDA Approves Gardasil 9 HPV Vaccine. American Cancer Society webpage. Available at: http://www.cancer.org/cancer/news/news/fda-approves-gardasil-9-hpv-vaccine. 1/8/2015. Accessed 2/20/2015.
Singh A, Arthur B, Agarwal V. LEEP Verses Cryotherapy in CIN. Journal of obstetrics and gynaecology of India. Aug 2011;61(4):431-435.
Slattery ML, Abbott TM, Overall JC Jr, Robison LM, French TK, Jolles C, et al. Dietary vitamins A, C, and E and selenium as risk factors for cervical cancer. Epidemiology. 1990;1(1):8-15.
Soper D. Reducing the health burden of HPV infection through vaccination. Infectious diseases in obstetrics and gynecology. 2006;2006 Suppl:83084.
Storck S. NIH (National Institutes of Health) MedlinePlus webpage. Cervical dysplasia. Available at: http://www.nlm.nih.gov/medlineplus/ency/article/001491.htm. Last updated 2/24/2014. Accessed 2/2/2015.
Sun J. Vitamin D and mucosal immune function. Current opinion in gastroenterology. Nov 2010;26(6):591-595.
Sundström H, Yrjänheikki E, Kauppila A. Low serum selenium concentration in patients with cervical or endometrial cancer. Int J Gynaecol Obstet. 1984;22(1):35-40.
Tomita LY, Longatto Filho A, Costa MC, Andreoli MA, Villa LL, Franco EL, Cardoso MA. Diet and serum micronutrients in relation to cervical neoplasia and cancer among low-income Brazilian women. International journal of cancer. Journal international du cancer. Feb 1 2010;126(3):703-714.
UDo HPV Test. 2014. https://www.udotest.com/test/udo-hpv-test. Last accessed 9/7/2014.
Van Belle TL, Gysemans C, Mathieu C. Vitamin D in autoimmune, infectious and allergic diseases: a vital player? Best practice & research. Clinical endocrinology & metabolism. Aug 2011;25(4):617-632.
Van den Bergh JM, Guerti K, Willemen Y, Lion E, Cools N, Goossens H, . . . Smits EL. HPV vaccine stimulates cytotoxic activity of killer dendritic cells and natural killer cells against HPV-positive tumour cells. Journal of cellular and molecular medicine. Jul 2014;18(7):1372-1380.
VanEenwyk J, Davis FG, Bowen PE. Dietary and serum carotenoids and cervical intraepithelial neoplasia. International journal of cancer. Journal international du cancer. Apr 22 1991;48(1):34-38.
VanEenwyk J, Davis FG, Colman N. Folate, vitamin C, and cervical intraepithelial neoplasia. Cancer Epidemiol Biomarkers Prev. 1992;1(2):119-24.
Verhoeven V, Renard N, Makar A, et al. Probiotics enhance the clearance of human papillomavirus-related cervical lesions: a prospective controlled pilot study. Eur J Cancer Prev. 2013;22(1):46-51.
Wang JT, Ding L, Jiang SW, Hao J, Zhao WM, Zhou Q, . . . Zhang L. Folate deficiency and aberrant expression of DNA methyltransferase 1 were associated with cervical cancerization. Current pharmaceutical design. 2014;20(11):1639-1646.
Wee CC, McCarthy EP, Davis RB, Phillips RS. Screening for cervical and breast cancer: is obesity an unrecognized barrier to preventive care? Ann Intern Med. May 2 2000;132(9):697-704.
Weinstein SJ, Ziegler RG, Selhub J, Fears TR, Strickler HD, Brinton LA, . . . Stolley PD. Elevated serum homocysteine levels and increased risk of invasive cervical cancer in US women. Cancer causes & control: CCC. May 2001;12(4):317-324.
Weppner DM, Alvero R. Ferri's Clinical Advisor. Cervical Dysplasia. Available at: www.clinicalkey.com. Copyright © 2014. Accessed 7/11/2014.
Wheeler CM, Hunt WC, Joste NE, Key CR, Quint WG, Castle PE. Human papillomavirus genotype distributions: implications for vaccination and cancer screening in the United States. J Natl Cancer Inst. 2009;101:475–87.
Xu J, Dennehy P, Keyserling H, Westerman LE, Wang Y, Holman RC, . . . Jiang B. Serum antibody responses in children with rotavirus diarrhea can serve as proxy for protection. Clinical and diagnostic laboratory immunology. Feb 2005;12(2):273-279.
Yermak IM, Kim Y, Titlynov E, Isakov V, Solov'eva T. Chemical structure and gel properties of carrageenans from algae belonging to the Gigartinaceae and Tichocarpaceae, collected from the Russian Pacific coast. Journal of Applied Phycology. 1999;11(1):41-48.
Zanotti K, Singh S. Cervical malignancy/dysplasia. First Consult. Available at: www.clinicalkey.com. Last updated 1/7/2014. Accessed 7/11/2014. 2014.
Zhang X, Dai B, Zhang B, Wang Z. Vitamin A and risk of cervical cancer: a meta-analysis. Gynecol Oncol. 2012;124(2):366-73.
Ziegler RG, Weinstein SJ, Fears TR. Nutritional and genetic inefficiencies in one-carbon metabolism and cervical cancer risk. The Journal of nutrition. Aug 2002;132(8 Suppl):2345s-2349s.